3 Patents
- US123904642025Treatment of EGFR Mutant-related Cancers Using a Combination of EGFR and CDK4/6 Inhibitors
BETA PHARMA, Inc.
0 cites - US122583652025Organophosphorus-substituted Compounds as C-met Inhibitors and Therapeutic Uses Thereof
BETA PHARMA, Inc.
0 cites